Detection of intracranial metastases: A multicenter, intrapatient comparison of gadobenate dimeglumine-enhanced MRI with routinely used contrast agents at equal dosage

Investigative Radiology

Volumn 36, Issue 2, 2001, Pages 72-81

  Colosimo, Cesare ^a   Ruscalleda, Jordi ^b   Korves, Matthias ^c   La Ferla, Roberto ^d   Wool, Corinne ^d   Pianezzola, Paola ^d   Kirchin, Miles A ^d  

^a UNIVERSITY OF CHIETI   (Italy)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d Bracco SpA   (Italy)

Author keywords

Brain metastases; Gadobenate dimeglumine; Intracranial metastases; MR contrast agent; MRI; MultiHance

Indexed keywords

GADOBENATE DIMEGLUMINE; GADODIAMIDE; GADOLINIUM PENTETATE; GADOTERIC ACID;

ARTICLE; BRAIN METASTASIS; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; HUMAN; IMAGE QUALITY; LUNG CANCER; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; OVARY CANCER; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE CANCER; QUALITATIVE DIAGNOSIS; QUANTITATIVE DIAGNOSIS;

EID: 0035125779     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-200102000-00002     Document Type: Article

References (19)

1. Management of brain metastases
2. Brain metastases
3. Rationale and clinical indications for contrast agents in MR imaging of the brain and spine
4. Diagnostic accuracy of MRI compared to CCT in patients with brain metastasis
5. The application of contrast agents in the evaluation of neoplasms of the central nervous system
6. Experience with high-dose gadolinium MR imaging in the evaluation of brain metastases
7. Detection of brain metastases: Comparison of contrast-enhanced MR with unenhanced MR and enhanced CT
8. The effect of contrast dose, imaging time, and lesion size in the MR detection of intracerebral metastasis
9. Improved contrast of enhancing brain lesions on postgadolinium, T1-weighted spin-echo images with use of magnetization transfer
10. Contrast-enhanced magnetisation transfer MRI in metastatic lesions of the brain
11. MR imaging detection of cerebral metastases with a single injection of high-dose gadoteridol
12. Triple-dose versus standard-dose gadopentetate dimeglumine: A randomized study in 199 patients
13. Gadobenate dimeglumine 0.5 M solution for injection (MultiHance®): Pharmaceutical formulation and physico-chemical properties of a new magnetic resonance imaging contrast medium
14. Gadobenate dimeglumine 0.5 M solution for injection (MultiHance®) as contrast agent for magnetic resonance imaging of the liver: Mechanistic studies in animals
15. Gadolinium chelates with weak binding to serum proteins
16. Evaluation of the safety and efficacy of gadobenate dimeglumine (Gd-BOPTA) in MRI of CNS metastatic lesions
17. White matter disease of the elderly - Vascular etiologies
18. Vascular causes of white matter disease
19. Hepatocellular carcinoma: Correlation between gadobenate dimeglumine-enhanced MRI and pathologic findings